Drawing for APAFIX SG+

USPTO serial 79355309

APAFIX SG+

Reviewed by CopyMark Law Group

Reg. 7171984Status 700Registered
Filing date
Status date
Registration date
Sep 26, 2023
Examiner
POWERS, ALEXANDER L
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with APAFIX SG+?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Cytological fixatives; histological fixatives; chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; chemical preparations for scientific purposes, other than for medical or veterinary use; chemical preparations for use in dna analysis for scientific purposes; chemical products for use in science to fix biological samples, in particular those which are deemed parasitological; chemical reagent mixtures in kit form, other than for medical or veterinary use; chemical reagent mixtures in tablet form for testing water; chemical reagent mixtures, other than for medical or veterinary use; chemical reagents for identification of microorganisms, other than for medical or veterinary use; chemical reagents for laboratory use, other than for medical or veterinary use; chemical reagents for the chemical fixing of biological samples, in particular those which are deemed parasitological in nature in molecular biology, other than for medical or veterinary use; chemical reagents for susceptibility determinations, other than for medical or veterinary use; chemical reagents for use in analytical tests for the chemical fixing of biological samples, in particular those which are deemed parasitological in nature, other than for medical or veterinary use; chemical reagents for use in biotechnology for the chemical fixing of biological samples, particularly those containing parasitological organisms, other than for medical or veterinary use; chemical reagents for use in scientific diagnosis, other than for medical or veterinary use; chemical reagents for use in scientific diagnostic tests, other than for medical or veterinary use; chemical reagents for use in science to chemically fix biological samples, in particular intestinal parasites, other than for medical or veterinary use; chemical reagents for use with immunoassay analyzers, other than for medical or veterinary use; chemical reagents used to chemically fix biological samples, in particular intestinal parasites, other than for medical or veterinary purpose; chemical substances for scientific analyses in laboratories, other than for medical or veterinary purposes; chemical substances for use in separation of faecal material and the concentration of parasitic ova, oocysts and other organisms for pre-analytical and diagnostic purposes; chemical test reagents for the chemical fixing of biological samples, particularly those containing parasitological organisms; chemically treated test strips, other than for medical purposes, for the chemical fixing of biological samples, particularly those containing parasitological organisms; chemicals, namely, those involved in the molecular and morphological preservation of biological samples for use in analysis of nucleic acids, proteins, cellular structures and all other related biological processes; chemicals for use in chromatography; chemicals for use in fuel as microbial growth inhibitors; chemicals for use in immuno-assay testing, other than for medical or veterinary use; chemicals for use in molecular separation processes, for laboratory or research use; chemicals for use in multiplying nucleic acid amounts, for laboratory or research use; chemicals for use in pathology, for laboratory or research use; chemicals for use in performing nucleic acid polymerase chain reactions, for laboratory or research use; chemicals for use in radiochemical analysis, for laboratory or research use; chemicals for use in science; chemicals for use in scientific research; chemicals, namely, those applied in the safe fixation of hazardous biological material for use in separation of hazardous biological samples; chemicals, namely, for use in separation techniques for faecal analysis; chemicals used in laboratory analyses, other than for medical and veterinary purposes; diagnostic chemicals for scientific use; diagnostic chemicals for use in antibiotic susceptibility testing, other than for medical or veterinary use; diagnostic chemical reagents, chemical reagents other than for medical or veterinary purposes; chemical substances, chemical materials and chemical preparations, and natural elements, all for analyses in laboratories, other than for medical or veterinary use; chemical compositions and materials for use in scienceACTIVE
005Preparations for destroying parasites; medical diagnostic reagents; medical diagnostic reagents and assays for testing of body fluids; chemical diagnostic reagents for medical use; chemical preparations for medical purposes, namely, for parasitology, bacteriology, virology and histology; chemical preparations for testing blood for medical purposes; chemical preparations for use in dna analysis, for medical purposes and veterinary purposes; chemical reagents for medical or veterinary purposes; chemical reagents for medical use; chemical test reagents, for medical purposes; diagnostic chemical reagents for medical use; diagnostic chemical reagents for medical or veterinary purposes; parasiticides; antiparasitic collars for animals; parasiticides for medical use; diagnostic preparations for medical purposes; medical dressings, medical plasters, and transdermal patches containing pharmaceutical preparations for application to the skin; pharmaceuticals and natural remedies for the treatment of intestinal parasites; biochemical preparations for medical use for the treatment of intestinal parasites; biochemical preparations for veterinary use for the treatment of intestinal parasites; biological preparations for medical purposes for the treatment of intestinal parasites; biological preparations for veterinary purposes for the treatment of intestinal parasites; chemical preparations for medical purposes for the treatment of intestinal parasites; chemical preparations for veterinary purposes for the treatment of intestinal parasites; enzyme preparations for medical purposes; enzyme preparations for veterinary purposes; enzymes for medical purposes; enzymes for veterinary purposes; medical preparations for the treatment of intestinal parasites; medicines for veterinary purposes for the treatment of intestinal parasites; microbicides; microbiocides for industrial and institutional manufacturing processes and wastewater applications; mixed biological preparations for medical purposes for the treatment of intestinal parasites; pharmaceutical preparations for animals for the treatment of intestinal parasites; pharmaceutical preparations for veterinary use for the treatment of microorganisms, in particular those that are parasitological in nature; reagents for medical use; reagents for use in medical genetic testing; reagents for use in veterinary genetic testing; veterinary preparations for the treatment of intestinal parasites; veterinary preparations and substances for the treatment of intestinal parasites; chemicals, namely, having antimicrobial properties in as far as they preserve biological samples and organisms whilst making them safe for observation and further testingACTIVE
010Medical and veterinary apparatus and instruments, namely, fixative containing devices utilised in the filtration and separation of biologically hazardous samples; medical apparatus and devices, namely, fixative containing devices utilised in the filtration and separation of biologically hazardous samples; medical apparatus and instruments, namely, fixative containing devices utilised in the filtration and separation of biologically hazardous samples; medical devices, namely, fixative containing devices utilised in the filtration and separation of biologically hazardous samples; medical diagnostic apparatus for medical purposes, namely, fixative containing devices utilised in the filtration and separation of biologically hazardous samples; medical diagnostic instruments, namely, fixative containing devices utilised in the filtration and separation of biologically hazardous samples; medical instruments, namely, fixative containing devices utilised in the filtration and separation of biologically hazardous samples; medical instruments for infectious disease testing in the field of microbiology; medical specimen cups; medical testing instruments in the field of microbiology; diagnostic, examination, and monitoring equipment in the field of microbiology for medical purposes; diagnostic, examination, and monitoring equipment in the field of microbiology for veterinary purposes; drug delivery applicators, sold empty; medical applicators; applicators for pharmaceutical preparations; receptacles for applying medicinesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 30, 2024FINVFINAL DECISION TRANSACTION PROCESSED BY IB
Jan 5, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB
Jan 4, 2024FIMPFINAL DISPOSITION PROCESSED
Dec 26, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 26, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 26, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 11, 2023GPNXNOTIFICATION PROCESSED BY IB
Jul 11, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 11, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 21, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 21, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 21, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 23, 2023PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY
May 7, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
May 6, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED
May 5, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
May 5, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 25, 2023RFNTREFUSAL PROCESSED BY IB
Apr 4, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 4, 2023RFRRREFUSAL PROCESSED BY MPU
Feb 16, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 15, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 11, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED
Feb 9, 2023DOCKASSIGNED TO EXAMINER
Dec 2, 2022MAFRAPPLICATION FILING RECEIPT MAILED
Nov 28, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 25, 2022LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED
Nov 17, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance